These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12077213)

  • 1. Phosphodiesterase 1B knock-out mice exhibit exaggerated locomotor hyperactivity and DARPP-32 phosphorylation in response to dopamine agonists and display impaired spatial learning.
    Reed TM; Repaske DR; Snyder GL; Greengard P; Vorhees CV
    J Neurosci; 2002 Jun; 22(12):5188-97. PubMed ID: 12077213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase 1B differentially modulates the effects of methamphetamine on locomotor activity and spatial learning through DARPP32-dependent pathways: evidence from PDE1B-DARPP32 double-knockout mice.
    Ehrman LA; Williams MT; Schaefer TL; Gudelsky GA; Reed TM; Fienberg AA; Greengard P; Vorhees CV
    Genes Brain Behav; 2006 Oct; 5(7):540-51. PubMed ID: 17010100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-1B (PDE1B) enzyme.
    Siuciak JA; McCarthy SA; Chapin DS; Reed TM; Vorhees CV; Repaske DR
    Neuropharmacology; 2007 Jul; 53(1):113-24. PubMed ID: 17559891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotensin regulates DARPP-32 thr34 phosphorylation in neostriatal neurons by activation of dopamine D1-type receptors.
    Matsuyama S; Higashi H; Maeda H; Greengard P; Nishi A
    J Neurochem; 2002 Apr; 81(2):325-34. PubMed ID: 12064480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum.
    Nishi A; Kuroiwa M; Miller DB; O'Callaghan JP; Bateup HS; Shuto T; Sotogaku N; Fukuda T; Heintz N; Greengard P; Snyder GL
    J Neurosci; 2008 Oct; 28(42):10460-71. PubMed ID: 18923023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D(1) dopamine receptor activation reduces GABA(A) receptor currents in neostriatal neurons through a PKA/DARPP-32/PP1 signaling cascade.
    Flores-Hernandez J; Hernandez S; Snyder GL; Yan Z; Fienberg AA; Moss SJ; Greengard P; Surmeier DJ
    J Neurophysiol; 2000 May; 83(5):2996-3004. PubMed ID: 10805695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine and cyclic AMP-regulated phosphoprotein-32 phosphorylation pattern in cocaine and morphine-sensitized rats.
    Scheggi S; Rauggi R; Gambarana C; Tagliamonte A; De Montis MG
    J Neurochem; 2004 Aug; 90(4):792-9. PubMed ID: 15287884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mesolimbic dopaminergic response to novel palatable food consumption increases dopamine-D1 receptor-mediated signalling with complex modifications of the DARPP-32 phosphorylation pattern.
    Rauggi R; Scheggi S; Cassanelli A; De Montis MG; Tagliamonte A; Gambarana C
    J Neurochem; 2005 Feb; 92(4):867-77. PubMed ID: 15686489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor Skill Learning Is Associated with Phase-Dependent Modifications in the Striatal cAMP/PKA/DARPP-32 Signaling Pathway in Rodents.
    Qian Y; Forssberg H; Diaz Heijtz R
    PLoS One; 2015; 10(10):e0140974. PubMed ID: 26488498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling.
    Nishi A; Liu F; Matsuyama S; Hamada M; Higashi H; Nairn AC; Greengard P
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1322-7. PubMed ID: 12538871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic interactions of dopamine D1 and glutamate NMDA receptors in rat hippocampus and prefrontal cortex: involvement of ERK1/2 signaling.
    Sarantis K; Matsokis N; Angelatou F
    Neuroscience; 2009 Nov; 163(4):1135-45. PubMed ID: 19647050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons.
    Svenningsson P; Lindskog M; Rognoni F; Fredholm BB; Greengard P; Fisone G
    Neuroscience; 1998 May; 84(1):223-8. PubMed ID: 9522376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonistic effects of dopaminergic signaling and ethanol on protein kinase A-mediated phosphorylation of DARPP-32 and the NR1 subunit of the NMDA receptor.
    Edwards S; Simmons DL; Galindo DG; Doherty JM; Scott AM; Hughes PD; Wilcox RE
    Alcohol Clin Exp Res; 2002 Feb; 26(2):173-80. PubMed ID: 11964556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of DARPP-32 dephosphorylation at PKA- and Cdk5-sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase-2A.
    Nishi A; Bibb JA; Matsuyama S; Hamada M; Higashi H; Nairn AC; Greengard P
    J Neurochem; 2002 May; 81(4):832-41. PubMed ID: 12065642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphodiesterase-1b (Pde1b) knockout mice are resistant to forced swim and tail suspension induced immobility and show upregulation of Pde10a.
    Hufgard JR; Williams MT; Skelton MR; Grubisha O; Ferreira FM; Sanger H; Wright ME; Reed-Kessler TM; Rasmussen K; Duman RS; Vorhees CV
    Psychopharmacology (Berl); 2017 Jun; 234(12):1803-1813. PubMed ID: 28337525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors.
    Svenningsson P; Lindskog M; Ledent C; Parmentier M; Greengard P; Fredholm BB; Fisone G
    Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1856-60. PubMed ID: 10677546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mGlu5R promotes glutamate AMPA receptor phosphorylation via activation of PKA/DARPP-32 signaling in striatopallidal medium spiny neurons.
    Dell'anno MT; Pallottino S; Fisone G
    Neuropharmacology; 2013 Mar; 66():179-86. PubMed ID: 22507666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32.
    Dunah AW; Sirianni AC; Fienberg AA; Bastia E; Schwarzschild MA; Standaert DG
    Mol Pharmacol; 2004 Jan; 65(1):121-9. PubMed ID: 14722243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the cAMP/PKA/DARPP-32 signaling pathway is required for morphine psychomotor stimulation but not for morphine reward.
    Borgkvist A; Usiello A; Greengard P; Fisone G
    Neuropsychopharmacology; 2007 Sep; 32(9):1995-2003. PubMed ID: 17251906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DARPP-32: regulator of the efficacy of dopaminergic neurotransmission.
    Fienberg AA; Hiroi N; Mermelstein PG; Song W; Snyder GL; Nishi A; Cheramy A; O'Callaghan JP; Miller DB; Cole DG; Corbett R; Haile CN; Cooper DC; Onn SP; Grace AA; Ouimet CC; White FJ; Hyman SE; Surmeier DJ; Girault J; Nestler EJ; Greengard P
    Science; 1998 Aug; 281(5378):838-42. PubMed ID: 9694658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.